Founded in 2001, Montrose Capital Partners is a privately held investment firm based in Miami, Florida. Led by CEO Mark Tompkins, Montrose focuses on identifying Public Markets Venture Capital investment opportunities — investing in high-growth early-stage companies across global industries.
Montrose invests across biotechnology, specialty pharmaceuticals, medical devices, robotics, AI, nuclear energy, and semiconductors. Their philosophy: seek unique investments in high-growth sectors where management has a financial stake and is committed to growth — leveraging public market exposure to unlock strategic opportunities.
With 27+ investments and 17 IPOs in its portfolio — including companies like Augmedix, Transphorm, SmartKem, and Ekso Bionics — Montrose Capital Partners has demonstrated a strong track record in deep tech and life sciences. The firm believes public market access offers companies critical advantages for equity, debt, and strategic partnerships.
"We believe exposure to public markets offers companies more opportunities to access equity, debt, and strategic partnerships — creating value for management and investors alike."
Apply to the Apex Startup Discovery Program
Aligned with Montrose Capital Partners's investment focus. Precondition: You must be an Apex Participant to submit. Registration is complimentary and includes 2 Golden Ads. This project is part of Apex Master Expos.
Apex Ecosystem with Golden Ads
"Who I Am · What I Want"
Complimentary for Apex Participants. Become an Apex Participant at myapex.me — registration is complimentary and includes 2 Golden Ads. Part of Apex Master Expos.
Apex is a living ecosystem — one of its kind. A decentralized, member-owned global business platform across 80+ countries where preferred venture partners such as Montrose Capital Partners can explore early-stage innovation quietly and selectively, while founders showcase on their MySite and gain clarity on what long-term investors truly seek. No middleman. By members, for members.